Firas El Chaer

University of Virginia Hospital

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Ashkan Emadi

University of Maryland School of Medicine

UNITED STATES

View details

Roy F. Chemaly

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Hans H. Hirsch

SWITZERLAND

View details

Bryan Hambley

University of Cincinnati

UNITED STATES

View details

Sarah Kashanian

University of Texas Southwestern Medical Center

UNITED STATES

View details

Kelly Norsworthy

Adjunct Assistant Professor

Johns Hopkins Hospital

UNITED STATES

View details

Shernan Holtan

Assistant Professor

University of Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Firas El Chaer

Research Interests

Explore related searches

Contact this professor

Articles (12)

Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?

American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies

MRD in ALL: Optimization and Innovations

Variant Acute Promyelocytic Leukemia Presenting Without Auer Rods Highlights the Need for Correlation with Cytogenetic Data in Leukemia Diagnosis.

Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.

<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification

Increased body mass index is a risk factor for acute promyelocytic leukemia.

Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.

Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore.

Collaborators (7)

Ashkan Emadi

Roy F. Chemaly

Hans H. Hirsch

Bryan Hambley

Sarah Kashanian

Kelly Norsworthy

Shernan Holtan

Make your next move.